Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study-Reference-Cited by-全球学者库

Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study

Published:2020-03 Issue:3 Volume:5 Page:267-275
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Chen Ying-Xuan,Gao Qin-Yan,Zou Tian-Hui,Wang Bang-Mao,Liu Si-De,Sheng Jian-Qiu,Ren Jian-Lin,Zou Xiao-Ping,Liu Zhan-Ju,Song Yan-Yan,Xiao Bing,Sun Xiao-Min,Dou Xiao-Tan,Cao Hai-Long,Yang Xiao-Ning,Li Na,Kang Qian,Zhu Wei,Xu Hong-Zhi,Chen Hui-Min,Cao Xiao-Chuang,Fang Jing-Yuan

Funder

National Natural Science Foundation of China

Shanghai Shenkang Hospital Development Center

China and Shanghai Municipal Education Commission-Gaofeng Clinical Medicine

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia;Cotton;Crit Rev Oncog,1996

3. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths;Zauber;N Engl J Med,2012